Amendment of Schedule 2 to the principal Regulations17.

In Schedule 2 to the principal Regulations (applications in respect of pharmaceutical lists and procedures to be followed)—

(a)

in paragraph 7 (additional information to be included with routine applications), in sub-paragraph (1)(b), for “Trust,” substitute “Trust),”;

(b)

in the heading of paragraph 13 (which relates to the functions of the NHSCB in relation to fitness information relevant to applications, where it already holds fitness information that may be relevant to future applications), for “applications from bodies corporate” substitute “applications: aggregation of information”;

(c)

in paragraph 31 (conditional grant of applications where the address of the premises is unknown), after sub-paragraph (3) insert the following sub-paragraph—

“(3A)

For the purposes of paragraph (3), premises are not within the range of possible locations covered by the estimate referred to in sub-paragraph (1)(b) if the granted application would have been refused pursuant to regulation 31 if the address of those premises had been included in that application instead of the estimate.”; and

(d)

in paragraph 32 (changes to the premises specified in an application after its grant but before the listing of the premises), after sub-paragraph (3) insert the following sub-paragraph—

“(3A)

A notification under sub-paragraph (2) is not valid if the granted application would have been refused pursuant to regulation 31 if the address of those premises had been included in that application instead of the address mentioned in sub-paragraph (1)(b).”.